Physician profile
John D Davis
NPI 1932160652
$1,772.47
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $670 · 2021: $326 · 2022: $22.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $291.39 | 2019-2021 | |
| Novo Nordisk INC | $264.82 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $223.94 | 2019-2021 | |
| Lilly USA, LLC | $170.05 | 2019-2021 | |
| Pfizer INC. | $137.74 | 2019-2020 | |
| Glaxosmithkline, LLC. | $101.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $88.31 | 2019-2021 | |
| Dexcom, INC. | $84.28 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.18 | 2019-2021 | |
| Zealand Pharma US, INC. | $67.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $55.43 | 2019 | |
| Abbvie INC. | $54.49 | 2021-2022 | |
| Amgen INC. | $33.68 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.44 | 2020-2021 | |
| Allergan, INC. | $24.90 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $18.88 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.98 | 2021 | |
| Esperion Therapeutics, INC. | $12.07 | 2020 | |
| Irhythm Technologies, INC. | $12.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.27 | 2019 | |
| Genentech USA, INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.